Back
DexCom, Inc. 10K Form
Buy
55
DXCM
DexCom, Inc.
Last Price:
$65.28
Seasonality Move:
11.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | DXCM/DexCom, Inc. Quarterly |
| 2023-10-26 | 10Q | DXCM/DexCom, Inc. Quarterly |
| 2023-07-27 | 10Q | DXCM/DexCom, Inc. Quarterly |
| 2023-04-27 | 10Q | DXCM/DexCom, Inc. Quarterly |
| 2022-10-27 | 10Q | DXCM/DexCom, Inc. Quarterly |
| 2022-07-28 | 10Q | DXCM/DexCom, Inc. Quarterly |
Receive DXCM News And Ratings
See the #1 stock for the next 7 days that we like better than DXCM
DXCM Financial Statistics
Sales & Book Value
| Annual Sales: | $4B |
|---|---|
| Cash Flow: | $579.4M |
| Price / Cash Flow: | 24.88 |
| Annual Sales: | $6.99 |
| Price / Book: | 9.28 |
Profitability
| EPS (TTM): | 1.79680 |
|---|---|
| Net Income (TTM): | $720.7M |
| Gross Margin: | $2.4B |
| Return on Equity: | 30.94% |
| Return on Assets: | 10.47% |
DexCom, Inc. Earnings Forecast
Key DexCom, Inc. Financial Ratios
-
The Gross Profit Margin over the past 24 years for DXCM is 60.29%.
-
The Selling, General & Administrative Expenses for DXCM have been equal to 31.88% of Gross Profit Margin.
-
The Research & Development expenses have been 13.53% of Revenue.
-
The Interest Expense is 3.30% of Operating Income.
-
The Net Earning history of DXCM is 14.29% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 13 years.
DexCom, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | DXCM |
| CUSIP: | 252131 |
| Website: | dexcom.com |
Debt
| Debt-to-Equity Ratio: | 0.94 |
|---|---|
| Current Ratio: | 1.56 |
| Quick Ratio: | 1.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 45.54 |
|---|---|
| Forward P/E Ratio: | 26.07 |
DXCM Technical Analysis vs Fundamental Analysis
Buy
55
DexCom, Inc. (DXCM)
is a Buy
Is DexCom, Inc. a Buy or a Sell?
-
DexCom, Inc. stock is rated a BuyThe current DexCom, Inc. [DXCM] share price is $64.85. The Score for DXCM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.